 Ancrod was intensively studied in ischemic stroke, starting at least by the early 1990s.An RCT called "STAT" was published in 2000; it included 500 subjects and ancrod or placebo was administered within three hours of the stroke.Ancrod showed modest benefits but a trend toward increased intracranial haemorrhage.